FacebookTwitterGoogle+RedditEmail

Is Testosterone the New Estrogen?

by MARTHA ROSENBERG

It’s only been ten years since estrogen replacement was huckstered as a sexual fountain of youth. Women don’t lose their hormones because they get old, they get old because they lose their hormones was the lucrative sales pitch. Hormone replacement therapy was practically a right of passage for US women–promised as the way to keep their looks and husbands, making billions for Wyeth which is now Pfizer.

But ten years ago a federal study found hormone replacement drugs in women greatly increased the risk of breast cancer, ovarian cancer, heart attacks, stroke, blood clots and dementia, The one-size-fits-all hormone replacement was not just worthless–it was causing many of the things it was supposed to prevent.

Public health agencies and medical groups had major egg on their face when millions of women quit hormones in 2003. The incidence of breast cancer in the US fell actually fell seven percent and 15 percent for tumors fed by estrogen. Heart attacks in women also fell. The “cause” of cancer was in clear site and it wasn’t lifestyle, genetics or environmental factors–it was Big Pharma!

It was even more embarrassing to public health officials because the whole sequence had occurred before. The same drops in cancer had been seen thirty years earlier when estrogen-only therapy was used. At that time, women quit hormone therapy then because of its links to endometrial cancer…whereupon progesterone was added to prevent endometrial cancer. Who can say short memory?

It’s no secret that testosterone is the new estrogen for both men and women. Marketed to men, it is a way to stay young and virile and maintain “performance” as the radio ads say. Marketed to women, testosterone is a way to recapture waning sexual desire and boost the libido. Two new pills to boost women’s libidos are under consideration by the FDA. One contains testosterone and adds sildenafil, the active ingredient in Viagra. The other contains testosterone with the antidepressant buspirone. The drugs have a peppermint-flavored testosterone coating said to “melt in the mouth” allowing the second ingredient to kick in. They are advancing in the FDA approval process and expected to be cleared for larger clinical trials soon. If all goes well, they could be on the market in two years.

Yet marketing male hormones to women is not new and not without controversy. A testosterone patch made by Procter & Gamble to increase women’s sexual desire has already been rejected by the FDA. Some say Intrinsa, denied approval by the FDA in 2004, failed to fly because it came too soon after the Vioxx debacle which many attributed to the FDA’s hasty, industry-friendly approval. Marketed as a super aspirin for everyday arthritis or menstrual discomfort, Vioxx resulted in 88,000 heart attacks and 38,000 deaths before it was withdrawn from the market, according to published reports.

Intrinsa produced only “small improvements in sexual parameters and large placebo responses,” said a review in Drug and Therapeutics Bulletin that proved a nail in the drug’s coffin. “Unwanted side effects are common and not always reversible.” Who can guess what those side effects are? Nor did it help that three women testified during FDA hearings for Intrinsa that they had developed breast cancer while using it.

Have public health officials, doctors and women learned anything from the first two hormone marketing scourges? Or will testosterone be number three?

Martha Rosenberg is an investigative health reporter. She is the author of  Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health (Prometheus).

 

 

Martha Rosenberg is an investigative health reporter. She is the author of  Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health (Prometheus).

More articles by:

CounterPunch Magazine

minimag-edit

bernie-the-sandernistas-cover-344x550

zen economics

January 24, 2017
Anthony DiMaggio
Reflections on DC: Promises and Pitfalls in the Anti-Trump Uprising
Sharmini Peries - Michael Hudson
Developer Welfare: Trump’s Infrastructure Plan
Melvin Goodman
Trump at the CIA: the Orwellian World of Alternative Facts
Sam Mitrani – Chad Pearson
A Short History of Liberal Myths and Anti-Labor Politics
Kristine Mattis
Democracy is Not a Team Sport
Andrew Smolski
Third Coast Pillory: Mexico, Neo-Nationalism and the Capitalist World-System
Ted Rall
The Women’s March Was a Dismal Failure and a Hopeful Sign
Norman Pollack
Women’s March: Halt at the Water’s Edge
Pepe Escobar
Will Trump Hop on an American Silk Road?
Franklin Lamb
Trump’s “Syria “Minus Iran” Overture to Putin and Assad May Restore Washington-Damascus Relations
Kenneth R. Culton
Violence By Any Other Name
David Swanson
Why Impeach Donald Trump
Christopher Brauchli
Trump’s Contempt
January 23, 2017
John Wight
Trump’s Inauguration: Hail Caesar!
Mark Schuller
So What am I Doing Here? Reflections on the Inauguration Day Protests
Patrick Cockburn
The Rise of Trump and Isis Have More in Common Than You Might Think
Binoy Kampmark
Ignored Ironies: Women, Protest and Donald Trump
Gregory Barrett
Flag, Cap and Screen: Hollywood’s Propaganda Machine
Gareth Porter
US Intervention in Syria? Not Under Trump
L. Ali Khan
Trump’s Holy War against Islam
Gary Leupp
An Al-Qaeda Attack in Mali:  Just Another Ripple of the Endless, Bogus “War on Terror”
Norman Pollack
America: Banana Republic? Far Worse
Bob Fitrakis - Harvey Wasserman
We Mourn, But We March!
Kim Nicolini
Trump Dump: One Woman March and Personal Shit as Political
William Hawes
We Are on Our Own Now
Martin Billheimer
Last Tango in Moscow
Colin Todhunter
Development and India: Why GM Mustard Really Matters
Mel Gurtov
Trump’s America—and Ours
David Mattson
Fog of Science II: Apples, Oranges and Grizzly Bear Numbers
Clancy Sigal
Who’s Up for This Long War?
Weekend Edition
January 20, 2017
Friday - Sunday
Paul Street
Divide and Rule: Class, Hate, and the 2016 Election
Andrew Levine
When Was America Great?
Jeffrey St. Clair
Roaming Charges: This Ain’t a Dream No More, It’s the Real Thing
Yoav Litvin
Making Israel Greater Again: Justice for Palestinians in the Age of Trump
Linda Pentz Gunter
Nuclear Fiddling While the Planet Burns
Ruth Fowler
Standing With Standing Rock: Of Pipelines and Protests
David Green
Why Trump Won: the 50 Percenters Have Spoken
Dave Lindorff
Imagining a Sanders Presidency Beginning on Jan. 20
Pete Dolack
Eight People Own as Much as Half the World
Roger Harris
Too Many People in the World: Names Named
Steve Horn
Under Tillerson, Exxon Maintained Ties with Saudi Arabia, Despite Dismal Human Rights Record
John Berger
The Nature of Mass Demonstrations
Stephen Zielinski
It’s the End of the World as We Know It
David Swanson
Six Things We Should Do Better As Everything Gets Worse
Alci Rengifo
Trump Rex: Ancient Rome’s Shadow Over the Oval Office
FacebookTwitterGoogle+RedditEmail